Literature DB >> 33275711

How to evaluate for immunodeficiency in patients with autoimmune cytopenias: laboratory evaluation for the diagnosis of inborn errors of immunity associated with immune dysregulation.

Roshini S Abraham1.   

Abstract

The identification of genetic disorders associated with dysregulated immunity has upended the notion that germline pathogenic variants in immune genes universally result in susceptibility to infection. Immune dysregulation (autoimmunity, autoinflammation, lymphoproliferation, and malignancy) and immunodeficiency (susceptibility to infection) represent 2 sides of the same coin and are not mutually exclusive. Also, although autoimmunity implies dysregulation within the adaptive immune system and autoinflammation indicates disordered innate immunity, these lines may be blurred, depending on the genetic defect and diversity in clinical and immunological phenotypes. Patients with immune dysregulatory disorders may present to a variety of clinical specialties, depending on the dominant clinical features. Therefore, awareness of these disorders, which may manifest at any age, is essential to avoid a protracted diagnostic evaluation and associated complications. Availability of and access to expanded immunological testing has altered the diagnostic landscape for immunological diseases. Nonetheless, there are constraints in using these resources due to a lack of awareness, challenges in systematic and logical evaluation, interpretation of results, and using results to justify additional advanced testing, when needed. The ability to molecularly characterize immune defects and develop "bespoke" therapy and management mandates a new paradigm for diagnostic evaluation of these patients. The immunological tests run the gamut from triage to confirmation and can be used for both diagnosis and refinement of treatment or management strategies. However, the complexity of testing and interpretation of results often necessitates dialogue between laboratory immunologists and specialty physicians to ensure timely and appropriate use of testing and delivery of care.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 33275711      PMCID: PMC7727558          DOI: 10.1182/hematology.2020000173

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  64 in total

1.  Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4.

Authors:  Sangmoon Lee; Jin Soo Moon; Cho-Rong Lee; Hye-Eun Kim; Sun-Mi Baek; Solha Hwang; Gyeong Hoon Kang; Jeong Kee Seo; Choong Ho Shin; Hyoung Jin Kang; Jae Sung Ko; Sung Gyoo Park; Murim Choi
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

2.  Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases.

Authors:  Anna Mensa-Vilaró; María Bravo García-Morato; Oscar de la Calle-Martin; Clara Franco-Jarava; María Teresa Martínez-Saavedra; Luis I González-Granado; Eva González-Roca; Jose Luis Fuster; Laia Alsina; Osvaldo M Mutchinick; Angélica Balderrama-Rodríguez; Eduardo Ramos; Consuelo Modesto; Pablo Mesa-Del-Castillo; Norberto Ortego-Centeno; Daniel Clemente; Alejandro Souto; Natalia Palmou; Agustín Remesal; Kieron S Leslie; Enrique Gómez de la Fuente; Luz Yadira Bravo Gallego; Josep María Campistol; Naouel Guirat Dhouib; Mohamed Bejaoui; Lívia Almeida Dutra; Maria Teresa Terreri; Catalina Mosquera; Tatiana González; Jerónima Cañellas; José María García-Ruiz de Morales; Carine H Wouters; María Teresa Bosque; Weng Tarng Cham; Santiago Jiménez-Treviño; Jaime de Inocencio; Markéta Bloomfield; Rebeca Pérez de Diego; Natalia Martínez-Pomar; Rebeca Rodríguez-Pena; Cecilia González-Santesteban; Pere Soler-Palacín; Ferran Casals; Jordi Yagüe; Luis M Allende; José Carlos Rodríguez-Gallego; Roger Colobran; Laura Martínez-Martínez; Eduardo López-Granados; Juan I Aróstegui
Journal:  J Allergy Clin Immunol       Date:  2018-09-29       Impact factor: 10.793

3.  CD21(-/low) B cells in human blood are memory cells.

Authors:  K Thorarinsdottir; A Camponeschi; N Cavallini; O Grimsholm; L Jacobsson; I Gjertsson; I-L Mårtensson
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

4.  Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.

Authors:  Omar S Qureshi; Yong Zheng; Kyoko Nakamura; Kesley Attridge; Claire Manzotti; Emily M Schmidt; Jennifer Baker; Louisa E Jeffery; Satdip Kaur; Zoe Briggs; Tie Z Hou; Clare E Futter; Graham Anderson; Lucy S K Walker; David M Sansom
Journal:  Science       Date:  2011-04-07       Impact factor: 47.728

Review 5.  Somatic mosaicism in primary immune deficiencies.

Authors:  Taizo Wada; Fabio Candotti
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-12

Review 6.  The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects.

Authors:  Bodo Grimbacher; Klaus Warnatz; Patrick F K Yong; Anne-Sophie Korganow; Hans-Hartmut Peter
Journal:  J Allergy Clin Immunol       Date:  2016-01       Impact factor: 10.793

7.  Characterization of CTLA4 Trafficking and Implications for Its Function.

Authors:  Sahamoddin Khailaie; Behzad Rowshanravan; Philippe A Robert; Erin Waters; Neil Halliday; Jesus David Badillo Herrera; Lucy S K Walker; David M Sansom; Michael Meyer-Hermann
Journal:  Biophys J       Date:  2018-08-23       Impact factor: 4.033

8.  Whole-genome sequencing of a sporadic primary immunodeficiency cohort.

Authors:  James E D Thaventhiran; Hana Lango Allen; Oliver S Burren; William Rae; Daniel Greene; Emily Staples; Zinan Zhang; James H R Farmery; Ilenia Simeoni; Elizabeth Rivers; Jesmeen Maimaris; Christopher J Penkett; Jonathan Stephens; Sri V V Deevi; Alba Sanchis-Juan; Nicholas S Gleadall; Moira J Thomas; Ravishankar B Sargur; Pavels Gordins; Helen E Baxendale; Matthew Brown; Paul Tuijnenburg; Austen Worth; Steven Hanson; Rachel J Linger; Matthew S Buckland; Paula J Rayner-Matthews; Kimberly C Gilmour; Crina Samarghitean; Suranjith L Seneviratne; David M Sansom; Andy G Lynch; Karyn Megy; Eva Ellinghaus; David Ellinghaus; Silje F Jorgensen; Tom H Karlsen; Kathleen E Stirrups; Antony J Cutler; Dinakantha S Kumararatne; Anita Chandra; J David M Edgar; Archana Herwadkar; Nichola Cooper; Sofia Grigoriadou; Aarnoud P Huissoon; Sarah Goddard; Stephen Jolles; Catharina Schuetz; Felix Boschann; Paul A Lyons; Matthew E Hurles; Sinisa Savic; Siobhan O Burns; Taco W Kuijpers; Ernest Turro; Willem H Ouwehand; Adrian J Thrasher; Kenneth G C Smith
Journal:  Nature       Date:  2020-05-06       Impact factor: 49.962

9.  Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers.

Authors:  David Egg; Charlotte Schwab; Annemarie Gabrysch; Peter D Arkwright; Edmund Cheesman; Lisa Giulino-Roth; Olaf Neth; Scott Snapper; Satoshi Okada; Michel Moutschen; Philippe Delvenne; Ann-Christin Pecher; Daniel Wolff; Yae-Jean Kim; Suranjith Seneviratne; Kyoung-Mee Kim; Ji-Man Kang; Samar Ojaimi; Catriona McLean; Klaus Warnatz; Maximilian Seidl; Bodo Grimbacher
Journal:  Front Immunol       Date:  2018-09-10       Impact factor: 7.561

Review 10.  Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside.

Authors:  Ottavia Maria Delmonte; Riccardo Castagnoli; Enrica Calzoni; Luigi Daniele Notarangelo
Journal:  Front Pediatr       Date:  2019-08-27       Impact factor: 3.418

View more
  4 in total

Review 1.  Inborn Errors of Immunity in the Premature Infant: Challenges in Recognition and Diagnosis.

Authors:  Scott M Gordon; Amy E O'Connell
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 8.786

Review 2.  Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes.

Authors:  Valentina Boz; Chiara Zanchi; Laura Levantino; Guglielmo Riccio; Alberto Tommasini
Journal:  World J Clin Pediatr       Date:  2022-03-09

Review 3.  Defining and targeting patterns of T cell dysfunction in inborn errors of immunity.

Authors:  Jose S Campos; Sarah E Henrickson
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

4.  Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.

Authors:  Ebe Schiavo; Beatrice Martini; Enrico Attardi; Filippo Consonni; Sara Ciullini Mannurita; Maria Luisa Coniglio; Marco Tellini; Elena Chiocca; Ilaria Fotzi; Laura Luti; Irene D'Alba; Marinella Veltroni; Claudio Favre; Eleonora Gambineri
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.